■This year marks the 84th anniversary of Chong Kun Dang, and the company's corporate image is changing for the first time in over 50 years. Chong Kun Dang unveiled a new image on the 7th that expresses its growth into the world. In the 1950s, shortly after the war, the company included a cross (+) in its image, symbolizing sacrifice, service, and health. In the 1960s, it depicted a bell and a circle to symbolize respect for life and the perfection of the universe. In the 1970s, it added the English phrase, 'BETTER LIFE THROUGH BETTER MEDICINE.' The new image features a prominently depicted bell and uses the Chong Kun Dang futuristic font.
■Celltrion recently announced on the 7th that it revealed the post-analysis results of the Phase 3 clinical trial of Jimpentra (ingredient name infliximab) at the '2025 American Gastroenterology Association' held in San Diego, United States. The analysis focused on patients with Crohn's disease and ulcerative colitis, assessing the results one and two years after the Phase 3 trial of Jimpentra. The results indicated that patients losing drug response during the maintenance therapy showed specific indicators from the beginning in their baseline characteristics and clinical response patterns. The company noted that early dose escalation could be an effective treatment.
■Digital therapeutics corporation Hi announced on the 7th that it plans to exhibit three digital health artificial intelligence (AI) products at 'Bio Korea 2025.' Notable products include GlucoCheck, which allows non-invasive blood glucose measurement, MindCheck, which measures emotional disorders, and BrainCheck, which screens for dementia within five minutes. GlucoCheck utilizes a self-developed artificial intelligence algorithm to predict blood glucose levels, and it will be unveiled for the first time at this event.
■Medical startup Mediark announced on the 7th that it has received a 3 billion won pre-Series A investment from JB Investment. Mediark has developed its own AI preliminary consultation app called 'Symtomi.' Symtomi provides a summary that can be delivered to healthcare professionals when users input their symptoms in their native language. Symtomi received an excellence award at the foreign resident support case competition organized by the Ministry of the Interior and Safety last year.